about
Expression of circulating miRNAs associated with lymphocyte differentiation and activation in CLL-another piece in the puzzle.Guilty bystanders: nurse-like cells as a model of microenvironmental support for leukemic lymphocytes.Examination of the FLT3 and NPM1 mutational status in patients with acute myeloid leukemia from southeastern Poland.Primary central nervous system lymphoma as a neurosurgical problem.Diagnosis and treatment of acquired hemophilia: a single -center experience.Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia.Central nervous involvement by chronic lymphocytic leukaemia.BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features.Treatment of multiple myeloma patients with autologous stem cell transplantation - a fresh analysis.Assessment of the efficacy of ofatumumab in patients with chronic lymphocytic leukaemia treated in the Department of Haematooncology and Bone Marrow Transplantation of the Medical University in Lublin - Prelimary results.Detection of chromosomal changes in chronic lymphocytic leukemia using classical cytogenetic methods and FISH: application of rich mitogen mixtures for lymphocyte cultures.Assessment of the pathway of apoptosis involving PAR-4, DAXX and ZIPK proteins in CLL patients and its relationship with the principal prognostic factors.Natural killer-like T CD3+/CD16+CD56+ cells in chronic lymphocytic leukemia: intracellular cytokine expression and relationship with clinical outcome.[Unusual cases of non-Hodgkin's lymphomas--case reports][Expression of CD5 antigen in B and T cells from umbilical cord blood, from blood of healthy adults and patients with chronic lymphocytic B-cell leukemia (PBL-B)][Morbidity of multiple myeloma in material from the Hematology Clinic AM in Lublin after the accident in Chernobyl]Intravascular B-cell lymphoma in a 38-year-old woman: a case reportIntracellular interleukin-2 expression by T-cell subsets in B-cell chronic lymphocytic leukemia[CD43 in B-cell chronic lymphocytic leukemia][A case of chronic B cell lymphocytic leukemia with expression of CD8 antigen on leukemic cells][Influence of abnormalities of TP53 and ATM genes for course of B-cell chronic lymphocytic leukemia][T lymphocyte subpopulations in B-cell chronic lymphocytic leukemia patients with a different percentage of CD4+ helper T cells in bone marrow][Some genomic aberrations in B-cell chronic lymphocytic leukemia and their clinical relevance. Part I. B-cell lymphocytic leukemia with TP53 gene deletion][Some genomic aberrations in B-cell chronic lymphocytic leukemia and their clinical relevance. Part II. Trisomy 12 in B-cell chronic lymphocytic leukemia detected by fluorescence in situ hybridization]ZAP-70 and CD38 expression are independent prognostic factors in patients with B-cell chronic lymphocytic leukaemia and combined analysis improves their predictive valueThe clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemiaCirculating microenvironment of CLL: are nurse-like cells related to tumor-associated macrophages?Intraventricular treatment of secondary central nervous system lymphoma - Case study and literature overviewEfficacy and safety of the obinutuzumab-chlorambucil combination in the frontline treatment of elderly CLL patients with comorbidities - Polish Adult Leukemia Group (PALG) real-life analysisRichter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma
P50
Q33364071-6549CB83-A355-414A-9CF4-EB187E8073CBQ35020381-95847DBD-F9B1-4BF4-A333-9FB85787224EQ36582324-B2F88BAA-C358-4BA6-8BFA-2EC5CC376126Q39286225-3E650179-DCEC-4D0C-85FC-2012D0BB7814Q45874077-D8E3BE74-9597-4A41-838A-CD1E94EF2118Q46013515-BB67F493-D1D4-4DEE-8ACD-714C56D4949EQ47606743-BFA3AF72-CBBF-4A68-BBCB-073B60EB589EQ47939939-EE222491-539D-481E-8142-A87E889110E4Q51021847-85BF71C3-3047-422E-B059-7CB26AA3D53AQ52633156-9A4E541C-13FB-4B39-8919-103D555CC828Q52881604-C7794591-3852-412B-8F4A-741600B0C684Q54593792-AB336455-8344-403E-AA60-D26D2664EEDDQ54659767-7D24DFA5-9E06-41B8-BBCE-02D8ABFB7060Q73581697-A1AA1217-B6D3-451C-84E2-B5F18FEC933BQ73600188-7943114B-FA47-4F13-9D99-A043EF6175ECQ73973702-B815C362-BD7A-4133-806B-C97B2DEAB68DQ74006667-EFCFE60B-F67A-474D-AF3C-457A981FB9B8Q74033668-2091D227-3660-4C20-85B2-8F6AB16D0EFBQ74194068-5A3409CB-FF0A-492F-88EE-3EA08C7B43C2Q74826849-22E6216A-4863-49F6-83FD-23C7097F3E17Q77720443-7B85DCAB-5355-41BB-B1AC-046C7D79A8E7Q77999470-EDB9F021-E759-4E1A-AE4D-C0F20FF5EE56Q79842830-B0C2EB45-B77D-47BF-A103-F02ECEE73B59Q79842842-ACBCC79D-9F8B-4304-A539-A917AAE2F4FFQ81384807-2A437723-A368-43A9-84DE-8DD9B92C1A03Q82766574-D5326084-541D-4CB8-B198-8CCEA1ED430BQ85892388-8BB68FC0-2DA8-4628-86F7-760D508F9883Q88496899-A4422EA4-2333-4E46-BF56-FA622351CA3AQ90598333-36DBFAC1-009E-4779-8732-F015BE0931B0Q91196038-6AACD64D-BB5D-47EA-A814-19730B0680F2
P50
description
researcher
@en
wetenschapper
@nl
name
E Wasik-Szczepanek
@en
E Wasik-Szczepanek
@nl
type
label
E Wasik-Szczepanek
@en
E Wasik-Szczepanek
@nl
prefLabel
E Wasik-Szczepanek
@en
E Wasik-Szczepanek
@nl
P106
P31
P496
0000-0002-9715-3745